Estrofurate (AY-11483) is an impeded estrogen. it prevents ovulation and implantation.

Taleranol (also known as P-1560) a weak estrogen and a minor metabolite and epimer of the drug, zeranol. Zeranol is an anabolic agent that used in animal feed and is intended for human consumption, is noncarcinogenic, nonteratogenic, and nonmutagenic.

TS-410 (Amelometasone), is a topical anti-inflammatory steroid. Amelometasone lotion - external steroid preparation - is marketed in Japan.

Dimepregnen is an antiestrogen agent.

Norgesterone (norvinodrel, vinylestrenolone) is a progestin medication which was formerly used in birth control pills for women. The compound shows no androgenic and very little estrogenic activity; its progestational effect, as well as other properties, suggests its use as claudogenic agent. Norgesterone is an agonist of the progesterone receptor. It was used in combination with ethinylestradiol in birth control pills to prevent pregnancy.

Sanofi-Synthélabo has developed satavaptan (previously known as SR121463) as a non-peptidic vasopressin V2 receptor antagonist for the potential treatment for cardiovascular indications such as congestive heart failure (CHF) and hypertension. The drug reached phase II for these indications before the studies were discontinued. Satavaptan was also studied for the potential treatment of glaucoma. In addition, this drug was involved in phase III clinical trials in patients with ascites due to cirrhosis of the liver and in in patients with dilutional hyponatremia. However, the further development of the satavaptan was discontinued in 2009.

Rosterolone (also known as a17α-propylmesterolone) is a synthetic 5alpha-reduced steroid that was studied for acne treatment on animal models. It was shown that the topical administration was more effective than systemic treatment. Rosterolone exerted a potent topical sebosuppressive effect in the animal model. This compound has never been marketed.

Roxibolone, an androstane derivative, possesses the anti-glucocorticoid activity and devoid of any affinity for the androgenic prostate and muscle receptors. This anabolic drug has never been marketed.

Cortisuzol is a glucocorticoid corticosteroid, discovered by the French company Roussel Uclaf, and claimed to have anti-inflammatory activity in a number of clinical case reports.

Mipimazole was developed as a thyroid inhibitor. However, information about the further development of the drug is not available.